Abstract
A description is given of Searle's experience in implementing the WHO adverse reaction terminology in post-marketing surveillance.
Get full access to this article
View all access options for this article.
Filter Results
Select search scope: search across all journals or within the current journal
Search this journal
Enter search terms…
/